← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Polarean, Inc.
Durham, NC
$3,126,706
Total funding
2
Grants
Funding over time
peak $999.7K · FY2014–19$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,126,706 · 2
By mechanism
R44$2,978,230 · 1
R43$148,476 · 1
Investigators at Polarean, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
A Phase III Trial to Validate HP 129Xe MRI as a Functional Pulmonary Biomarker in Pediatric Lung Disease$999,713
R44 · FY2017 · HL
A Phase III Trial to Validate HP 129Xe MRI as a Functional Pulmonary Biomarker in Pediatric Lung Disease$999,402
R44 · FY2018 · HL
A Phase III Trial to Validate HP 129Xe MRI as a Functional Pulmonary Biomarker in Pediatric Lung Disease$979,115
R44 · FY2019 · HL
Enhanced Optical Module to Enable Polarized 129Xe MRI Use in Clinical Trials$148,476
R43 · FY2014 · HL